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Abstract
Background: Interleukin-21 (IL-21) is a T-cell-derived cytokine whose receptor is expressed on a variety of cells and
therefore might have pleiotropic roles in the pathogenesis of rheumatoid arthritis (RA). In this study, we investigated
the involvement of IL-21 signaling in the development of collagen-induced arthritis (CIA), an animal model of RA, using
IL-21 receptor knockout (Il21r KO) mice.
Methods: Il21r KO mice or wild-type (WT) C57BL/6 mice were immunized with chicken type II collagen (CII) emulsified
in complete Freund adjuvant on day 0 and were given a boost injection on day 21. The production of anti-CII
antibody, development of T-cell and B-cell subsets, and T-cell responses to CII were analyzed. CIA was induced in
Rag2 KO mice to which combinations of WT or Il21r KO CD4 T cells and WT or Il21r KO B cells had been transferred, in
order to examine the role of IL-21 signaling in each cell subset.
Results: Il21r KO mice were resistant to the development of CIA. CII-specific IgG but not IgM production was impaired
in Il21r KO mice. This is consistent with a reduction of germinal center B cells in the draining lymph nodes. In contrast,
CII-specific Th1 and Th17 responses were unaffected in Il21r KO mice. There was also no difference in the number of
CII-specific follicular helper T cells between WT and Il21r KO mice. By analyzing the development of CIA in T-cell
and B-cell mixed transfer experiments, we confirmed that IL-21 receptor expression on B cells, but not on T cells,
was essential for the development of CIA.
Conclusion: IL-21 signaling in B cells, but not in T cells, plays essential roles in the production of pathogenic
autoantibodies that induce CIA development.
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Background
Interleukin-21 (IL-21) is a member of the common cyto-
kine receptor γ-chain family of cytokines and is produced
primarily by activated T cells, especially by follicular helper
T (Tfh) cells, natural killer T (NKT) cells, and T-helper
cell type 17 (Th17) cells [1]. The IL-21 receptor (IL-21R)
is expressed on a variety of cells, including nonhemato-
poietic cells, and therefore IL-21 has a wide range of bio-
logical functions [1]. In CD4 T cells, IL-21 promotes the
development of Th17 and Tfh cells [2–4], while in B cells
it is involved in maintenance, class switching, and somatic
hypermutation [5–7].
Rheumatoid arthritis (RA) is characterized by chronic
inflammation of multiple joints, which is accompanied
by the production of autoantibodies, such as rheuma-
toid factor (RF) and anti-citrullinated protein antibody
(ACPA). IL-21R was upregulated in RA synovium [8]
while an increased frequency of IL-21-producing T
cells and high concentrations of IL-21 were observed
in the synovial fluid or serum of RA patients [9–12]. A
genetic association between IL-21 and RA has also
been reported [13]. IL-21 might therefore be involved
in the pathogenesis of RA, possibly via the induction
of pathogenic T-cell responses and/or autoantibody
production.
Collagen-induced arthritis (CIA) is a widely used animal
model of RA, and CIA can be induced by immunization
of mice (or rats) with type II collagen (CII). Many
pathological aspects of CIA resemble human RA. Most,
if not all, RA patients exhibit T-cell and B-cell re-
sponses to CII [14, 15]. Similar to human RA, the
MHC class II haplotype strongly influences the suscep-
tibility to CIA in mice, indicating the importance of
CD4 T-cell responses in pathogenesis [16, 17]. In fact,
CD4 T-cell depletion before immunization prevented
the development of CIA [18, 19]. The development of
CIA also depends on anti-CII antibody (Ab) production
because B-cell-deficient mice are totally resistant to the
induction of CIA [19, 20]. Thus, one of the roles of
CD4 T cells in the development of CIA is to help Ab
production by B cells. In addition, IL-17-producing
CD4 T cells (i.e., Th17 cells) are also implicated in the
development of CIA [21, 22].
Since IL-21 regulates the development of Th17 cells,
Tfh cells, as well as Ab-producing B cells, IL-21 is impli-
cated in the development of CIA. In fact, blocking IL-21
by administration of IL-21R-Fc after the onset of CIA
ameliorated the ongoing disease [23, 24]. However, the
detailed roles of IL-21 in the immune responses involved
in the development of CIA are yet to be determined. In
this study, we induced CIA in IL-21 receptor knockout
(Il21r KO) mice to analyze the roles of IL-21 signaling in




Wild-type (WT) C57BL/6 mice were purchased from
Charles River Japan (Yokohama, Japan). The generation
of Il21r KO mice was described previously [7]. Rag2 KO
mice were purchased from CREA Japan (Tokyo, Japan).
The mice were bred under specific pathogen-free condi-
tions in our institute and were used for the experiments
at 6–12 weeks of age.
Induction and assessment of CIA
Mice were immunized s.c. with 200 μg of chicken CII
(Collagen Research Center, Tokyo, Japan) emulsified in
50 μl Freund’s complete adjuvant (CFA) containing 250 μg
of Mycobacterium tuberculosis H37RA (DIFCO, Detroit,
MI, USA). Mice were boosted 3 weeks later with 200 μg
of CII emulsified in 50 μl CFA. The development of arth-
ritis was evaluated three times a week, and the severity of
arthritis was scored as follows: 1 point was assigned to an
inflamed (showing redness and/or swelling) digit, mid
paw, or ankle/wrist, but 2 points were assigned to digits if
more than one digit was inflamed. The sum of these
points was the score of each paw, and therefore the
maximum score was 4. The total score per mouse
ranged from 0 to 16.
Histological evaluation by hematoxylin and eosin staining
Mouse hind limbs were removed and the skin peeled off
before fixation with 10 % neutral buffered formalin.
After decalcification with 5 % formic acid, the samples
were embedded in paraffin and cut into 3 μm thick sec-
tions, which were mounted on glass slides and stained
with hematoxylin and eosin.
Measurement of serum anti-CII Ab levels
Serum levels of anti-CII Abs were measured by enzyme-
linked immunosorbent assay (ELISA). Briefly, microtiter
plates were coated with chicken CII (10 μg/ml) overnight
at 4 °C. After washing and blocking, serum samples were
added in serial dilutions and incubated for 2 h at room
temperature. After four washes, peroxidase-conjugated
goat anti-mouse IgG (KPL, Baltimore, MD, USA), rabbit
anti-mouse IgG1 (Invitrogen, Carlsbad, CA, USA), IgG2c
(Invitrogen), or biotin-conjugated anti-mouse IgM (II/41;
eBioscience, San Diego, CA, USA) was added and incu-
bated for 2 h at room temperature. For the anti-mouse
IgM, streptavidine–HRP (R&D System, Minneapolis, MN,
USA) was added after four washes and incubated for
30 min at room temperature. Ab binding was visualized
using TMBS (eBioscience).
Antibodies and flow cytometric analysis
FITC-conjugated anti-GL7 (GL7) and anti-CD278
(ICOS; C398.4A) mAbs were purchased from BioLegend
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(San Diego, CA, USA). Alexa Flour 488-conjugated
anti-IL-17A (TC11-18H10) mAb, allophycocyanin-
conjugated anti-CD45R (RA3-6B2) and anti-CD4
(RM4-5) mAbs, PE-conjugated CD95 (Jo2) mAbs and
streptavidin, PerCP-Cy5.5-conjugated anti-CD19 (1D3)
and anti-IFNγ (XMG1.2) mAbs, and biotin-conjugated
anti-CD185 (CXCR5; 2G8) mAbs were purchased from
BD Biosciences (San Jose, CA, USA). PE-conjugated
anti-CD154 (MR1) mAbs and PerCP-Cy5.5-conjugated
anti-IFNγ (XMG1.2) mAbs were purchased from
eBioscience. For cell surface staining, a single-cell sus-
pension was incubated with the optimal concentration
of fluorescent mAbs for 20 min at 4 °C. Intracellular
staining was performed using the BD Cytofix/Cytoperm
Kit (BD Biosciences) according to the manufacturer’s
instructions. Stained cells were run on a FACSCalibur
flow cytometer (BD Biosciences). In some experiments,
we added propidium iodide (1 μg/ml) to the cell sus-
pension just before running on the flow cytometer to
detect and exclude dead cells for the analysis. The data
were analyzed using BD CellQuest software Version 3.3
(BD Biosciences).
To detect antigen-specific T cells, intracellular CD154
expression was examined after ex-vivo stimulation with
the antigens as described previously [25]. Briefly, the
draining (inguinal) lymph node (LN) cells were cultured
for 18 h at 37 °C with denatured CII (100 μg/ml) or
purified protein derivative (PPD, 10 μg/ml; Japan BCG
Laboratory, Tokyo, Japan). Brefeldin A (10 μg/ml;
Sigma-Aldrich, St. Louis, MO, USA) was added to the
culture medium for the last 4 h. The cell culture medium
used in this study was RPMI 1640 (Wako Pure Chemical
Industries, Osaka, Japan) supplemented with 10 % FBS
(Cell Culture Technologies, Gravesano, Switzerland),
100 U/ml penicillin, 100 mg/ml streptomycin, and
0.5 mM 2-mercaptoethanol.
Measuring cytokine production of LN cells
Five weeks after immunization, the draining LN cells
were harvested and stimulated with denatured CII
(100 μg/ml) or PPD (10 μg/ml) at 1 × 107/well in 96-well
flat-bottomed plates for 72 h. Interferon gamma (IFN-γ)
and IL-17 production in the culture supernatant was
measured using ELISA kits (DuoSet; R&D System) ac-
cording to the manufacturer’s instructions.
Adoptive transfer of T cells and B cells into RAG2 KO mice
CD4 T cells were purified from the draining LN of WT
mice or Il21r KO mice 14 days after immunization with
CII/CFA using anti-CD4 microbeads and an autoMACS
cell separator (Miltenyi Biotec, Bergisch Gladbach,
Germany) according to the manufacturer’s instructions.
B cells were purified from the LNs and the spleens of
naïve WT mice or Il21r KO mice using PE-conjugated
anti-CD19 mAb (1D3; BD Bioscience) and anti-PE
microbeads (Miltenyi Biotec). The purity of both CD4+ T
cells and CD19+ B cells was greater than 95 %. The puri-
fied CD4+ T cells (3 × 107/μl) and B cells (1 × 108/μl) were
injected i.v. into Rag2 KO mice, which were subsequently
immunized with chicken CII and CFA to induce CIA. We
confirmed the presence of the transferred CD4+ T cells
and CD19+ B cells in the peripheral blood of recipient
RAG2 KO mice by flow cytometry prior to CII
immunization.
Statistics
Statistical significance was calculated using the log-rank
test, one-way ANOVA with a Turkey’s multiple compari-
son test, and two-way repeated-measure ANOVA by
Prism software version 4.0a (GraphPad Software). p < 0.05
was considered statistically significant.
Results
Il21r KO mice are resistant to the induction of CIA
Il21r KO mice or WT mice were immunized with CII
emulsified with CFA, followed by a booster injection
after 3 weeks. Arthritis started to develop in WT mice
about 1 week after the boost whereas Il21r KO mice
were highly resistant to the development of arthritis
(Fig. 1a, b). Histological examination showed no cellular
infiltrates in the joints of Il21r KO mice, while massive
synovitis with cartilage and bone destruction was detected
in WT mice (Fig. 1c).
Impaired CII-specific Ab production in Il21r KO mice
To elucidate the mechanism of CIA resistance in Il21r
KO mice, we measured anti-CII Abs in the serum. Al-
though there was no significant difference in the levels
of anti-CII IgM between WT mice and Il21r KO mice,
CII-specific IgG production, which was detected from
2 weeks after immunization, was severely impaired in
(See figure on previous page.)
Fig. 1 Il21r KO mice were resistant to CIA. Mice were immunized with chicken CII emulsified in CFA and were boosted 3 weeks later. Incidence
(a) and severity score (b) of CIA in WT mice (filled circle, n = 6) or Il21r KO mice (open square, n = 6). Clinical scores were calculated only in affected
mice. Each point represents mean ± SEM. Statistical significance was analyzed by the log-rank test (a) or two-way ANOVA with repeated measures
(b). p < 0.05, different between WT mice and Il21r KO mice. Data are representative of three independent experiments. c Histological examination
of the hind limb from WT mice (left panel) or Il21r KO mice (right panel) 50 days after immunization. The samples were stained with hematoxylin
and eosin (magnification: upper, ×40, lower, ×400). Il21r KO IL-21 receptor knockout, WT wild type
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Il21r KO mice (Fig. 2a, b). There was a significant de-
crease of CII-specific IgG1, while CII-specific IgG2c
tended to decrease in Il-21rKO mice (Fig. 2c). CII-
specific IgG2c was not different between naïve and
immunized Il21r KO mice (Fig. 2c).
IL-21 has been shown to be involved in germinal cen-
ter (GC) reactions [5]. Thus, we compared the number
of GC B cells in the draining LNs of WT mice and Il21r
KO mice. There was no difference in the number of total
B cells between WT mice and Il21r KO mice at any time
points (Fig. 3a). Although the numbers of GC B cells,
which were identified by the expression of GL7 and
CD95, were also comparable between WT mice and
Il21r KO mice before immunization, GC B cells increased
after immunization with CII only in WT mice (Fig. 3b, c).
IL-21 signaling is thus important for the generation
and/or expansion of GC B cells after antigen immunization.
Normal clonal expansion and cytokine production of
antigen-specific T cells in Il21r KO mice
We next examined CII-specific T-cell responses in Il21r
KO mice. In-vivo clonal expansion of antigen-specific T
cells was evaluated by detecting the intracellular ex-
pression of CD154 in CD4 T cells obtained from the
draining LNs after brief stimulation with the antigens
[25]. As shown in Fig. 4a, there was a clear population
of CD154-positive cells after stimulation with CII or
PPD, and there was no difference in the number of
antigen-specific CD4 T cells between WT mice and
Il21r KO mice (Fig. 4b). Since we could not detect anti-
gen-specific CD4 T cells that produced IFN-γ or IL-17 by
flow cytometric analysis, possibly because their frequency
was too low, we examined the levels of cytokines secreted
in the culture supernatants after stimulation with the anti-
gens. There was no difference in antigen-specific IL-17
and IFN-γ production between WT and KO T cells
(Fig. 4c, d). Consistent with this, we detected comparable
levels of T-cell proliferation after in-vitro restimulation
Fig. 2 CII-specific IgG production was suppressed in Il21r KO mice
with CIA. Levels of anti-CII IgM (a) and IgG (b) Abs in the serum of
WT mice (filled circle, n = 6) or Il21r KO (open circle, n = 6) mice during
the course of CIA. c Levels of anti-CII IgG1 (upper panel) and IgG2c
(lower panel) Abs in the serum of WT mice (gray column, n = 6) and
Il21r KO mice (open column, n = 6) at 5 weeks after CIA induction.
Sera from naïve WT mice were used as the negative control (filled
column, n = 6). Levels of anti-CII IgG1 and IgG2c Abs in the serum of
naïve Il21r KO mice were not different from those of naïve WT mice.
Error bars represent mean ± SEM. Statistical significance was analyzed
by two-way ANOVA with repeated measures (a, b) or one-way ANOVA
with Tukey’s multiple comparison test (c). *p < 0.05, different between
WT mice and Il21r KO mice or naïve and immunized mice. Data are
representative of three independent experiments. CII type II collagen,
Il21r KO IL-21 receptor knockout, O.D. optical density, WT wild type
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with the antigens by measuring 3H-thymidine uptake
(data not shown).
Normal Tfh cell development in Il21r KO mice
The development of Tfh cells in WT mice and Il21r KO
mice was examined by detecting CD4 T cells expressing
CXCR5 and ICOS. Although IL-21 was reported to be
involved in the development of Tfh cells [4], there was
no difference in the frequency or number of Tfh cells
between WT mice and Il21r KO mice (Fig. 5a, b). We
examined the development of antigen-specific Tfh cells
by analyzing cell populations that expressed CD154 after
in-vitro antigenic stimulation. There was no difference
in the number of CII-specific or PPD-specific Tfh cells
between WT mice and Il21r KO mice (Fig. 5c, d). We
could not detect CII-specific or PPD-specific IL-21-
producing T cells either by flow cytometric analysis or
ELISA (data not shown). IFN-γ or IL-17 production by
Tfh cells was not observed (data not shown).
Importance of IL-21-R on B cells in the development of CIA
The results described suggest that the lack of IL-21 sig-
naling affected pathogenic autoantibody production of B
cells without impairing T-cell functions. To confirm
whether the lack of IL-21 signaling in B cells is sufficient
for preventing the development of CIA, we conducted
adoptive transfer experiments in which B cells and T
cells from WT mice or Il21r KO mice in different
combinations were transferred into Rag2 KO recipient
mice. In the first set of experiments, Rag2 KO mice
were transferred with B cells from naïve WT mice or
Il21r KO mice together with CD4 T cells from CII-im-
munized WT mice. The recipients were then immunized
with CII to induce CIA. We found that the recipients to
which WT B cells were transferred developed arthritis,
whereas those receiving KO B cells did not (Fig. 6a). In the
other set of experiments, donor CD4 T cells were trans-
ferred either from WT mice or Il21r KO mice, but CIA de-
veloped in both recipients as long as they had been
transferred with WT B cells (Fig. 6b). These data indicate
that IL-21 signaling in B cells, but not in T cells, is indis-
pensable for the development of CIA.
Discussion
In the present study, we demonstrated that Il21r KO
mice were highly resistant to the development of CIA,
due to the lack of IL-21 signaling in B cells which is
essential for the production of pathogenic anti-CII
autoantibody. Several studies have examined the roles
of IL-21 in animal models of RA. Young et al. [23] ex-
amined the effect of blocking IL-21 in the effector
phase of CIA by administering IL-21R-Fc after the on-
set of arthritis. They observed a reduction of disease
severity, but the level of CII-specific Ab was not
Fig. 3 Germinal center (GC) B-cell responses were suppressed in Il21r
KO mice with CIA. a Absolute numbers of total B cells (CD19+CD45R
+ cells) of the draining LNs in WT mice (filled circle) or Il21r KO mice
(open square) during the course of CIA. b Representative dot plots of
GL7 and CD95 expression on B cells gated by B220 and CD19 at 0
or 35 days after CIA induction. Numbers (upper right quadrant) indicate
the percentage of CD95+GL7+ cells in B cells (CD19+B220+ cells).
c Absolute numbers of GC B cells (GL7+CD95+CD19+B220+ cells)
in the draining LNs of WT mice (filled circle) or Il21r KO mice (open
circle) during the course of CIA. Error bars represent mean ± SEM.
Statistical significance was analyzed by two-way ANOVA with repeated
measures (a, c). *p < 0.05, different between WT mice and Il21r KO
mice. Data are representative of three independent experiments. Il21r
KO IL-21 receptor knockout, WT wild type
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reduced. IL-21 blockade enhanced the production of
IFN-γ, IL-2, and GM-CSF, but reduced IL-17 and IL-6
production by splenocytes [23]. However, as the treat-
ment started at the effector stage of the disease, these
changes could be a consequence, but not necessarily
the cause, of the reduced inflammation. In this regard,
Block and Huang [26] made a detailed observation of
the roles of IL-21 signaling in immune responses in
the K/BxN mouse model of spontaneous arthritis.
Similar to our results, they demonstrated that IL-21R on
B cells was sufficient for the development of arthritis.
Their observation was made in cell transfer experiments,
however, and IL-21 might play an additional role in the
spontaneous development of arthritis in K/BxN mice. In
normal conditions, homeostatic expansion of KRN TCR
Tg T cells is a critical step for disease development, and
IL-21 was shown to be involved in this process [27]. In
contrast, in the case of CIA, CII-specific T cells are as-
sumed to expand after immunization with CII using
IL-2 as the growth factor, which is produced upon Ag
recognition by TCR.
The roles of IL-21 signaling in different immune cell
compartments have also been addressed in other models
of autoimmune diseases. For instance, McPhee et al. [28]
showed that IL-21 signaling in B cells, but not in T cells,
was required for the development of systemic lupus
erythematosus-like disease in BXSB mice using mixed
bone-marrow chimera mice. The essential role of IL-21
signaling in B cells is thus not limited to the pathogen-
esis of autoimmune arthritis.
Our data indicate that IL-21 signaling in T cells is dis-
pensable not only for the development of CIA but also
for the development of Th17 and Tfh cells. However,
earlier studies showed the role of IL-21 signaling in the
development of these CD4 T-cell subsets [3, 29]. Although
we cannot explain the reason for this discrepancy, similar
to our results, several studies have indicated that IL-21
signaling was dispensable for the development of Th17
Fig. 4 Antigen-specific CD4 T-cell responses were comparable between
WT and Il21r KO mice with CIA. a Representative dot plot analysis of
intracellular CD154 expression in WT (upper) or Il21r KO (lower) CD4 T
cells 35 days after CIA induction. CD154 within CD4 T cells was stained
after ex-vivo stimulation with nothing (left), CII (middle), or PPD (right).
Numbers (upper right quadrant) indicate the percentage of CD154+ cells
in CD4 T cells. b Absolute numbers of CD154+ CD4 T cells in WT mice
(filled symbols) or Il21r KO mice (open symbols) during the course of CIA.
IFN-γ (c) and IL-17 (d) secretion of draining LNs in WT mice (filled
column) or Il21r KO mice (open column) 35 days after CIA induction.
Both cytokines of supernatants were measured by ELISA after ex-vivo
stimulation with CII (middle) or PPD (right). Error bars represent mean ±
SEM. Statistical significance was analyzed by two-way ANOVA with
repeated measures (b–d). Data are representative of three independent
experiments. CII type II collagen, IFN interferon, IL interleukin, Il21r KO
IL-21 receptor knockout, PPD purified protein derivative, WT wild type
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cells [30, 31]. In addition, Th17 cells increased in Il21r KO
K/BxN mice [27], and it was later demonstrated that Th17
cells were not even required development of the disease
[26]. Although IL-21-induced STAT3 activation is in-
volved in the development of Th17 cells via the induction
of RORγt, IL-6 alone might induce sufficient levels of
STAT3 activation. In fact, IL-6 production is enhanced in
mice with CIA [32]. Similar to Th17 cells, Tfh cells were
shown to develop normally in Il21 KO mice and Il21r KO
mice [5, 33]. Although the molecular mechanisms of Tfh
development are not fully understand, the engagement of
TCR with high-affinity ligand and ICOS signaling were
shown to be involved in the development of Tfh cells,
in addition to STAT3-activating signals such as IL-6
and IL-21 [34, 35].
IL-21, which is produced by Tfh cells, plays a critical
role in the differentiation and proliferation of GC B cells
[6] through the regulation of Bcl-6 expression in B cells
[5]. Consistent with this, Il21r KO mice showed the im-
paired production of antigen-specific IgG1 [7]. There-
fore, it could be expected that IL-21 signaling in B cells
is also involved in CII-specific IgG production required
for the development of CIA. On the contrary, we did
not detect a difference in the levels of CII-specific IgM
production between WT mice and Il21r KO mice. This
might be because IL-21 signaling is not involved in the
activation of CII-specific naïve B cells first primed at the
border of T-cell and B-cell areas. Alternatively, such
IgM, if not all, is produced via an extrafollicular pathway
such as in MZ B cells. These results indicate that the
development of CIA depends on GC-derived autoanti-
bodies, although it is currently unclear whether isotype
class switching or affinity maturation, or both, is import-
ant for disease development.
IL-21 has been implicated in the pathogenesis of RA
and therefore is an emerging therapeutic target [24]. In
fact, clinical trials targeting IL-21 for the treatment of
RA are ongoing [36]. Our data suggest that targeting
Fig. 5 Development of Tfh cells was similar in WT and Il21r KO mice
with CIA. a Representative dot plots of CXCR5 and ICOS expression
on CD4 T cells 14 days after CIA induction. Numbers (upper right
quadrant) indicate the percentage of CXCR5+ICOS+ cells in CD4 T
cells. b Absolute numbers of Tfh cells (CXCR5+ICOS+CD4+ cells) in
the draining LNs of WT mice (filled circle) or Il21r KO mice (open
circle) during the course of CIA. c Representative dot plots of CXCR5
and ICOS expression in CD154+ CD4 T cells 14 days after CIA
induction. Numbers (upper right quadrant) indicate the percentage
of CXCR5+ICOS+ cells in CD154+ CD4 T cells. d Absolute numbers
of CII-specific Tfh cells (CXCR5+ICOS+CD154+CD4+ cells) in the
draining LNs of WT mice (filled column) or Il21r KO mice (open column)
during the course of CIA. Error bars represent mean ± SEM. Statistical
significance was analyzed by two-way ANOVA with repeated measures
(b, d). Data are representative of three independent experiments. CII
type II collagen, Il21r KO IL-21 receptor knockout, PPD purified protein
derivative, Tfh follicular helper T, WT wild type
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IL-21 might reduce autoimmune pathology induced by
autoantibodies, while preserving T-cell responses for
host defense against pathogens. It is also noteworthy
that affinity maturation of ACPA precedes the onset of
RA [37], raising a possibility that blocking IL-21 signal-
ing at this phase might prevent the onset of the disease.
Although it is currently difficult to precisely identify
those individuals at risk of developing RA, this is an
emerging topic [38]. Further investigation of the func-
tions of IL-21 in immune systems, especially in
humans, is required for the development of an optimal
IL-21-targeting therapy for RA.
Conclusions
We demonstrated in this study that IL-21 signaling in B
cells, but not in T cells, is involved in the development
of CIA, via the induction of pathogenic autoantibodies
against CII. IL-21 thus affects both the initiation and the
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